[
    {
        "id": 6935,
        "drug_name": "Zuranolone (SAGE-217)",
        "clinical_trial_id": "NCT04442490",
        "has_trial_insight_page": 0,
        "indication": "Postpartum Depression",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-04",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/SAGE\/news\/151119",
        "note": "Approved August 4, 2023.",
        "company_entity_id": 273,
        "company_ticker": "SAGE",
        "company_name": "Sage Therapeutics Inc.",
        "company_price": "20.3500",
        "company_change": -0.83,
        "company_percent_change": -3.92,
        "company_optionable": 1,
        "company_number_of_shares": 60106687,
        "price_change_sparkline": [
            [
                25.64,
                1706677200
            ],
            [
                26,
                1706763600
            ],
            [
                24.77,
                1706850000
            ],
            [
                24.27,
                1707109200
            ],
            [
                24.72,
                1707195600
            ],
            [
                23.91,
                1707282000
            ],
            [
                23.78,
                1707368400
            ],
            [
                23.69,
                1707454800
            ],
            [
                23.83,
                1707714000
            ],
            [
                23.02,
                1707800400
            ],
            [
                25.75,
                1707886800
            ],
            [
                25.41,
                1707973200
            ],
            [
                23.27,
                1708059600
            ],
            [
                22.17,
                1708405200
            ],
            [
                22.2,
                1708491600
            ],
            [
                22.25,
                1708578000
            ],
            [
                22.01,
                1708664400
            ],
            [
                22.63,
                1708923600
            ],
            [
                22.71,
                1709010000
            ],
            [
                22.55,
                1709096400
            ],
            [
                21.48,
                1709182800
            ],
            [
                21.86,
                1709269200
            ],
            [
                21.77,
                1709528400
            ],
            [
                21.23,
                1709614800
            ],
            [
                21.13,
                1709701200
            ],
            [
                21.37,
                1709787600
            ],
            [
                22.09,
                1709874000
            ],
            [
                21.18,
                1710129600
            ],
            [
                20.35,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6935,
        "drug_name": "Zuranolone (SAGE-217)",
        "clinical_trial_id": "NCT04442490",
        "has_trial_insight_page": 0,
        "indication": "Postpartum Depression",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-04",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/SAGE\/news\/151119",
        "note": "Approved August 4, 2023.",
        "company_entity_id": 375,
        "company_ticker": "BIIB",
        "company_name": "Biogen Inc.",
        "company_price": "227.3600",
        "company_change": -2.71,
        "company_percent_change": -1.1800000000000002,
        "company_optionable": 1,
        "company_number_of_shares": 145360798,
        "price_change_sparkline": [
            [
                246.66,
                1706677200
            ],
            [
                247.83,
                1706763600
            ],
            [
                243.72,
                1706850000
            ],
            [
                241.84,
                1707109200
            ],
            [
                245.55,
                1707195600
            ],
            [
                240.54,
                1707282000
            ],
            [
                240.3,
                1707368400
            ],
            [
                240.98,
                1707454800
            ],
            [
                244.74,
                1707714000
            ],
            [
                226.65,
                1707800400
            ],
            [
                220.74,
                1707886800
            ],
            [
                223.35,
                1707973200
            ],
            [
                219.08,
                1708059600
            ],
            [
                219.21,
                1708405200
            ],
            [
                221.11,
                1708491600
            ],
            [
                222.48,
                1708578000
            ],
            [
                223.32,
                1708664400
            ],
            [
                223.71,
                1708923600
            ],
            [
                223.94,
                1709010000
            ],
            [
                221.74,
                1709096400
            ],
            [
                216.99,
                1709182800
            ],
            [
                220.95,
                1709269200
            ],
            [
                221.02,
                1709528400
            ],
            [
                217.23,
                1709614800
            ],
            [
                217.56,
                1709701200
            ],
            [
                219.36,
                1709787600
            ],
            [
                223.24,
                1709874000
            ],
            [
                230.07,
                1710129600
            ],
            [
                227.36,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9571,
        "drug_name": "TALVEY (talquetamab-tgvs)",
        "clinical_trial_id": "NCT04634552",
        "has_trial_insight_page": 0,
        "indication": "Multiple myeloma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-10",
        "link": "https:\/\/www.investor.jnj.com\/files\/doc_news\/2023\/08\/FINAL_TALVEY-FDA-Approval-Press-Release_08-10-23.pdf",
        "note": "Approved August 10, 2023.",
        "company_entity_id": 380,
        "company_ticker": "JNJ",
        "company_name": "Johnson & Johnson",
        "company_price": "162.7400",
        "company_change": 1.51,
        "company_percent_change": 0.94,
        "company_optionable": 1,
        "company_number_of_shares": 2408767228,
        "price_change_sparkline": [
            [
                157.701248890579,
                1706677200
            ],
            [
                157.165322682896,
                1706763600
            ],
            [
                155.428524787625,
                1706850000
            ],
            [
                154.6246354761,
                1707109200
            ],
            [
                156.867585900849,
                1707195600
            ],
            [
                156.788189425637,
                1707282000
            ],
            [
                155.220109040193,
                1707368400
            ],
            [
                155.577393178648,
                1707454800
            ],
            [
                156.659170153417,
                1707714000
            ],
            [
                155.289580956004,
                1707800400
            ],
            [
                154.565088119691,
                1707886800
            ],
            [
                156.728642069228,
                1707973200
            ],
            [
                156.55,
                1708059600
            ],
            [
                157.86,
                1708405200
            ],
            [
                158.68,
                1708491600
            ],
            [
                160.45,
                1708578000
            ],
            [
                161.84,
                1708664400
            ],
            [
                160.79,
                1708923600
            ],
            [
                160.98,
                1709010000
            ],
            [
                161.55,
                1709096400
            ],
            [
                161.38,
                1709182800
            ],
            [
                162.12,
                1709269200
            ],
            [
                159.84,
                1709528400
            ],
            [
                159.97,
                1709614800
            ],
            [
                159.34,
                1709701200
            ],
            [
                158.87,
                1709787600
            ],
            [
                159.52,
                1709874000
            ],
            [
                161.23,
                1710129600
            ],
            [
                162.74,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10137,
        "drug_name": "AKEEGA (niraparib and abiraterone acetate)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "BRCA-positive mCRPC",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-11",
        "link": "https:\/\/www.investor.jnj.com\/files\/doc_news\/2023\/08\/AKEEGA-FDA-Approval-Press-Release_8-11.pdf",
        "note": "Approved August 11, 2023.",
        "company_entity_id": 380,
        "company_ticker": "JNJ",
        "company_name": "Johnson & Johnson",
        "company_price": "162.7400",
        "company_change": 1.51,
        "company_percent_change": 0.94,
        "company_optionable": 1,
        "company_number_of_shares": 2408767228,
        "price_change_sparkline": [
            [
                157.701248890579,
                1706677200
            ],
            [
                157.165322682896,
                1706763600
            ],
            [
                155.428524787625,
                1706850000
            ],
            [
                154.6246354761,
                1707109200
            ],
            [
                156.867585900849,
                1707195600
            ],
            [
                156.788189425637,
                1707282000
            ],
            [
                155.220109040193,
                1707368400
            ],
            [
                155.577393178648,
                1707454800
            ],
            [
                156.659170153417,
                1707714000
            ],
            [
                155.289580956004,
                1707800400
            ],
            [
                154.565088119691,
                1707886800
            ],
            [
                156.728642069228,
                1707973200
            ],
            [
                156.55,
                1708059600
            ],
            [
                157.86,
                1708405200
            ],
            [
                158.68,
                1708491600
            ],
            [
                160.45,
                1708578000
            ],
            [
                161.84,
                1708664400
            ],
            [
                160.79,
                1708923600
            ],
            [
                160.98,
                1709010000
            ],
            [
                161.55,
                1709096400
            ],
            [
                161.38,
                1709182800
            ],
            [
                162.12,
                1709269200
            ],
            [
                159.84,
                1709528400
            ],
            [
                159.97,
                1709614800
            ],
            [
                159.34,
                1709701200
            ],
            [
                158.87,
                1709787600
            ],
            [
                159.52,
                1709874000
            ],
            [
                161.23,
                1710129600
            ],
            [
                162.74,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9867,
        "drug_name": "DAXXIFY (DaxibotulinumtoxinA-lanm)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Cervical Dystonia",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-14",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/RVNC\/news\/152851",
        "note": "Approved on August 14, 2023.",
        "company_entity_id": 270,
        "company_ticker": "RVNC",
        "company_name": "Revance Therapeutics Inc.",
        "company_price": "6.2850",
        "company_change": 0.03,
        "company_percent_change": 0.4,
        "company_optionable": 1,
        "company_number_of_shares": 88214054,
        "price_change_sparkline": [
            [
                5.03,
                1706677200
            ],
            [
                5.15,
                1706763600
            ],
            [
                5.37,
                1706850000
            ],
            [
                5.1,
                1707109200
            ],
            [
                5.92,
                1707195600
            ],
            [
                5.38,
                1707282000
            ],
            [
                5.42,
                1707368400
            ],
            [
                5.91,
                1707454800
            ],
            [
                5.77,
                1707714000
            ],
            [
                5.22,
                1707800400
            ],
            [
                5.58,
                1707886800
            ],
            [
                5.58,
                1707973200
            ],
            [
                5.56,
                1708059600
            ],
            [
                5.51,
                1708405200
            ],
            [
                5.37,
                1708491600
            ],
            [
                5.31,
                1708578000
            ],
            [
                5.49,
                1708664400
            ],
            [
                5.69,
                1708923600
            ],
            [
                5.7,
                1709010000
            ],
            [
                5.66,
                1709096400
            ],
            [
                7.14,
                1709182800
            ],
            [
                6.98,
                1709269200
            ],
            [
                6.07,
                1709528400
            ],
            [
                6.5,
                1709614800
            ],
            [
                6.34,
                1709701200
            ],
            [
                6.16,
                1709787600
            ],
            [
                6.01,
                1709874000
            ],
            [
                6.26,
                1710129600
            ],
            [
                6.285,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7511,
        "drug_name": "ELREXFIO (elranatamab-bcmm)",
        "clinical_trial_id": "NCT04649359",
        "has_trial_insight_page": 1,
        "indication": "Multiple Myeloma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-14",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/152984",
        "note": "FDA Approved on August 14, 2023.",
        "company_entity_id": 845,
        "company_ticker": "ADPT",
        "company_name": "Adaptive Biotechnologies Corporation",
        "company_price": "3.5900",
        "company_change": -0.18999999999999995,
        "company_percent_change": -5.03,
        "company_optionable": 1,
        "company_number_of_shares": 145092271,
        "price_change_sparkline": [
            [
                3.67,
                1706677200
            ],
            [
                3.74,
                1706763600
            ],
            [
                3.65,
                1706850000
            ],
            [
                3.46,
                1707109200
            ],
            [
                3.77,
                1707195600
            ],
            [
                3.57,
                1707282000
            ],
            [
                3.67,
                1707368400
            ],
            [
                3.78,
                1707454800
            ],
            [
                3.92,
                1707714000
            ],
            [
                3.62,
                1707800400
            ],
            [
                3.94,
                1707886800
            ],
            [
                3.96,
                1707973200
            ],
            [
                3.85,
                1708059600
            ],
            [
                3.85,
                1708405200
            ],
            [
                3.82,
                1708491600
            ],
            [
                3.88,
                1708578000
            ],
            [
                4.04,
                1708664400
            ],
            [
                4.16,
                1708923600
            ],
            [
                4.27,
                1709010000
            ],
            [
                4.15,
                1709096400
            ],
            [
                4.11,
                1709182800
            ],
            [
                4.03,
                1709269200
            ],
            [
                3.99,
                1709528400
            ],
            [
                3.78,
                1709614800
            ],
            [
                3.61,
                1709701200
            ],
            [
                3.45,
                1709787600
            ],
            [
                3.65,
                1709874000
            ],
            [
                3.78,
                1710129600
            ],
            [
                3.59,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Breakthrough Therapy Designation (BTD)",
                "abbreviation": "BTD",
                "description": "Breakthrough Therapy Designation (BTD)",
                "description_html": "<p>Breakthrough Therapy Designation (BTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 7511,
        "drug_name": "ELREXFIO (elranatamab-bcmm)",
        "clinical_trial_id": "NCT04649359",
        "has_trial_insight_page": 1,
        "indication": "Multiple Myeloma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-14",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/152984",
        "note": "FDA Approved on August 14, 2023.",
        "company_entity_id": 387,
        "company_ticker": "PFE",
        "company_name": "Pfizer Inc.",
        "company_price": "28.0100",
        "company_change": -0.36,
        "company_percent_change": -1.27,
        "company_optionable": 1,
        "company_number_of_shares": 5646778425,
        "price_change_sparkline": [
            [
                27.08,
                1706677200
            ],
            [
                27.29,
                1706763600
            ],
            [
                26.93,
                1706850000
            ],
            [
                26.57,
                1707109200
            ],
            [
                27.5,
                1707195600
            ],
            [
                27.56,
                1707282000
            ],
            [
                27.57,
                1707368400
            ],
            [
                27.56,
                1707454800
            ],
            [
                27.66,
                1707714000
            ],
            [
                26.97,
                1707800400
            ],
            [
                27.11,
                1707886800
            ],
            [
                27.51,
                1707973200
            ],
            [
                27.62,
                1708059600
            ],
            [
                27.59,
                1708405200
            ],
            [
                27.67,
                1708491600
            ],
            [
                27.55,
                1708578000
            ],
            [
                27.76,
                1708664400
            ],
            [
                27.18,
                1708923600
            ],
            [
                26.89,
                1709010000
            ],
            [
                27.04,
                1709096400
            ],
            [
                26.56,
                1709182800
            ],
            [
                26.59,
                1709269200
            ],
            [
                25.89,
                1709528400
            ],
            [
                26.08,
                1709614800
            ],
            [
                27.19,
                1709701200
            ],
            [
                26.79,
                1709787600
            ],
            [
                27.22,
                1709874000
            ],
            [
                28.37,
                1710129600
            ],
            [
                28.01,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Breakthrough Therapy Designation (BTD)",
                "abbreviation": "BTD",
                "description": "Breakthrough Therapy Designation (BTD)",
                "description_html": "<p>Breakthrough Therapy Designation (BTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 6962,
        "drug_name": "HEPZATO (Melphalan\/HDS) - (FOCUS)",
        "clinical_trial_id": "NCT02678572",
        "has_trial_insight_page": 0,
        "indication": "Liver-dominant ocular melanoma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-14",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/DCTH\/news\/153105",
        "note": "FDA Approved on August 14, 2023.",
        "company_entity_id": 802,
        "company_ticker": "DCTH",
        "company_name": "Delcath Systems Inc.",
        "company_price": "3.8450",
        "company_change": -0.040000000000000036,
        "company_percent_change": -0.9,
        "company_optionable": 1,
        "company_number_of_shares": 22046101,
        "price_change_sparkline": [
            [
                4.79,
                1706677200
            ],
            [
                4.72,
                1706763600
            ],
            [
                4.705,
                1706850000
            ],
            [
                4.53,
                1707109200
            ],
            [
                4.68,
                1707195600
            ],
            [
                4.65,
                1707282000
            ],
            [
                4.58,
                1707368400
            ],
            [
                4.75,
                1707454800
            ],
            [
                4.78,
                1707714000
            ],
            [
                4.57,
                1707800400
            ],
            [
                4.71,
                1707886800
            ],
            [
                4.52,
                1707973200
            ],
            [
                4.4,
                1708059600
            ],
            [
                4.215,
                1708405200
            ],
            [
                4.21,
                1708491600
            ],
            [
                4.28,
                1708578000
            ],
            [
                4.32,
                1708664400
            ],
            [
                4.21,
                1708923600
            ],
            [
                4.23,
                1709010000
            ],
            [
                4.16,
                1709096400
            ],
            [
                4.17,
                1709182800
            ],
            [
                4.19,
                1709269200
            ],
            [
                4.18,
                1709528400
            ],
            [
                3.945,
                1709614800
            ],
            [
                3.9,
                1709701200
            ],
            [
                3.99,
                1709787600
            ],
            [
                3.985,
                1709874000
            ],
            [
                3.88,
                1710129600
            ],
            [
                3.845,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10475,
        "drug_name": "Sohonos (palovarotene)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Fibrodysplasia ossificans progressiva (FOP)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-16",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/IPSEY\/news\/153510",
        "note": "FDA Approved on August 16, 2023.",
        "company_entity_id": 2251,
        "company_ticker": "IPSEY",
        "company_name": "Ipsen ADR",
        "company_price": "29.1600",
        "company_change": 0.03,
        "company_percent_change": 0.1,
        "company_optionable": 0,
        "company_number_of_shares": 328117684,
        "price_change_sparkline": [
            [
                29.095,
                1706677200
            ],
            [
                28.85,
                1706763600
            ],
            [
                28.85,
                1706850000
            ],
            [
                28,
                1707109200
            ],
            [
                28.28,
                1707195600
            ],
            [
                29.2,
                1707282000
            ],
            [
                28.495,
                1707368400
            ],
            [
                28.664,
                1707454800
            ],
            [
                28.664,
                1707714000
            ],
            [
                28.22,
                1707800400
            ],
            [
                27.82,
                1707886800
            ],
            [
                28.5,
                1707973200
            ],
            [
                28.405,
                1708059600
            ],
            [
                28.874,
                1708405200
            ],
            [
                28.0425,
                1708491600
            ],
            [
                28.295,
                1708578000
            ],
            [
                28.4675,
                1708664400
            ],
            [
                28.06,
                1708923600
            ],
            [
                28.185,
                1709010000
            ],
            [
                27.67,
                1709096400
            ],
            [
                27.86,
                1709182800
            ],
            [
                27.74,
                1709269200
            ],
            [
                27.78,
                1709528400
            ],
            [
                27.498,
                1709614800
            ],
            [
                27.69,
                1709701200
            ],
            [
                28.69,
                1709787600
            ],
            [
                28.31,
                1709874000
            ],
            [
                29.13,
                1710129600
            ],
            [
                29.16,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10197,
        "drug_name": "Veopoz (pozelimab-bbfg)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Chaple",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-18",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/REGN\/news\/153870",
        "note": "Approved August 18, 2023.",
        "company_entity_id": 388,
        "company_ticker": "REGN",
        "company_name": "Regeneron Pharmaceuticals Inc.",
        "company_price": "970.5700",
        "company_change": 6.13,
        "company_percent_change": 0.64,
        "company_optionable": 1,
        "company_number_of_shares": 109761896,
        "price_change_sparkline": [
            [
                942.78,
                1706677200
            ],
            [
                957.78,
                1706763600
            ],
            [
                945.18,
                1706850000
            ],
            [
                936.33,
                1707109200
            ],
            [
                937.81,
                1707195600
            ],
            [
                938.49,
                1707282000
            ],
            [
                946.43,
                1707368400
            ],
            [
                953.42,
                1707454800
            ],
            [
                947.06,
                1707714000
            ],
            [
                940.48,
                1707800400
            ],
            [
                947.82,
                1707886800
            ],
            [
                954.73,
                1707973200
            ],
            [
                948.05,
                1708059600
            ],
            [
                946.87,
                1708405200
            ],
            [
                952.84,
                1708491600
            ],
            [
                964.89,
                1708578000
            ],
            [
                981.2,
                1708664400
            ],
            [
                989.28,
                1708923600
            ],
            [
                993.35,
                1709010000
            ],
            [
                987.61,
                1709096400
            ],
            [
                966.09,
                1709182800
            ],
            [
                982.82,
                1709269200
            ],
            [
                971.19,
                1709528400
            ],
            [
                965.21,
                1709614800
            ],
            [
                972.1,
                1709701200
            ],
            [
                973.31,
                1709787600
            ],
            [
                968.83,
                1709874000
            ],
            [
                964.44,
                1710129600
            ],
            [
                970.57,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6182,
        "drug_name": "INGREZZA (valbenazine)",
        "clinical_trial_id": "NCT04102579",
        "has_trial_insight_page": 0,
        "indication": "Huntington's disease",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-18",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/NBIX\/news\/153902",
        "note": "Approved August 18, 2023.",
        "company_entity_id": 205,
        "company_ticker": "NBIX",
        "company_name": "Neurocrine Biosciences Inc.",
        "company_price": "137.7400",
        "company_change": -0.87,
        "company_percent_change": -0.63,
        "company_optionable": 1,
        "company_number_of_shares": 99507490,
        "price_change_sparkline": [
            [
                139.77,
                1706677200
            ],
            [
                142.45,
                1706763600
            ],
            [
                141.74,
                1706850000
            ],
            [
                141.66,
                1707109200
            ],
            [
                142.96,
                1707195600
            ],
            [
                136.29,
                1707282000
            ],
            [
                134.42,
                1707368400
            ],
            [
                132.3,
                1707454800
            ],
            [
                130.43,
                1707714000
            ],
            [
                133.84,
                1707800400
            ],
            [
                131.77,
                1707886800
            ],
            [
                134,
                1707973200
            ],
            [
                132.31,
                1708059600
            ],
            [
                132.65,
                1708405200
            ],
            [
                130.65,
                1708491600
            ],
            [
                133.37,
                1708578000
            ],
            [
                134.18,
                1708664400
            ],
            [
                135.58,
                1708923600
            ],
            [
                136.03,
                1709010000
            ],
            [
                134.66,
                1709096400
            ],
            [
                130.4,
                1709182800
            ],
            [
                131.3,
                1709269200
            ],
            [
                133.12,
                1709528400
            ],
            [
                133.67,
                1709614800
            ],
            [
                132.25,
                1709701200
            ],
            [
                135.33,
                1709787600
            ],
            [
                139.22,
                1709874000
            ],
            [
                138.61,
                1710129600
            ],
            [
                137.74,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 8171,
        "drug_name": "EYLEA HD (aflibercept 8 mg)",
        "clinical_trial_id": "NCT04429503",
        "has_trial_insight_page": 1,
        "indication": "Wet age-related macular degeneration (wAMD), diabetic macular edema (DME) and diabetic retinopathy (DR)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-18",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/REGN\/news\/153911",
        "note": "Approved August 18, 2023.",
        "company_entity_id": 388,
        "company_ticker": "REGN",
        "company_name": "Regeneron Pharmaceuticals Inc.",
        "company_price": "970.5700",
        "company_change": 6.13,
        "company_percent_change": 0.64,
        "company_optionable": 1,
        "company_number_of_shares": 109761896,
        "price_change_sparkline": [
            [
                942.78,
                1706677200
            ],
            [
                957.78,
                1706763600
            ],
            [
                945.18,
                1706850000
            ],
            [
                936.33,
                1707109200
            ],
            [
                937.81,
                1707195600
            ],
            [
                938.49,
                1707282000
            ],
            [
                946.43,
                1707368400
            ],
            [
                953.42,
                1707454800
            ],
            [
                947.06,
                1707714000
            ],
            [
                940.48,
                1707800400
            ],
            [
                947.82,
                1707886800
            ],
            [
                954.73,
                1707973200
            ],
            [
                948.05,
                1708059600
            ],
            [
                946.87,
                1708405200
            ],
            [
                952.84,
                1708491600
            ],
            [
                964.89,
                1708578000
            ],
            [
                981.2,
                1708664400
            ],
            [
                989.28,
                1708923600
            ],
            [
                993.35,
                1709010000
            ],
            [
                987.61,
                1709096400
            ],
            [
                966.09,
                1709182800
            ],
            [
                982.82,
                1709269200
            ],
            [
                971.19,
                1709528400
            ],
            [
                965.21,
                1709614800
            ],
            [
                972.1,
                1709701200
            ],
            [
                973.31,
                1709787600
            ],
            [
                968.83,
                1709874000
            ],
            [
                964.44,
                1710129600
            ],
            [
                970.57,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6854,
        "drug_name": "ABRYSVO - (RSVpreF)",
        "clinical_trial_id": "NCT04424316",
        "has_trial_insight_page": 1,
        "indication": "Respiratory Syncytial Virus (RSV) in infants",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-21",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/154132",
        "note": "FDA approval on August 21, 2023.",
        "company_entity_id": 387,
        "company_ticker": "PFE",
        "company_name": "Pfizer Inc.",
        "company_price": "28.0100",
        "company_change": -0.36,
        "company_percent_change": -1.27,
        "company_optionable": 1,
        "company_number_of_shares": 5646778425,
        "price_change_sparkline": [
            [
                27.08,
                1706677200
            ],
            [
                27.29,
                1706763600
            ],
            [
                26.93,
                1706850000
            ],
            [
                26.57,
                1707109200
            ],
            [
                27.5,
                1707195600
            ],
            [
                27.56,
                1707282000
            ],
            [
                27.57,
                1707368400
            ],
            [
                27.56,
                1707454800
            ],
            [
                27.66,
                1707714000
            ],
            [
                26.97,
                1707800400
            ],
            [
                27.11,
                1707886800
            ],
            [
                27.51,
                1707973200
            ],
            [
                27.62,
                1708059600
            ],
            [
                27.59,
                1708405200
            ],
            [
                27.67,
                1708491600
            ],
            [
                27.55,
                1708578000
            ],
            [
                27.76,
                1708664400
            ],
            [
                27.18,
                1708923600
            ],
            [
                26.89,
                1709010000
            ],
            [
                27.04,
                1709096400
            ],
            [
                26.56,
                1709182800
            ],
            [
                26.59,
                1709269200
            ],
            [
                25.89,
                1709528400
            ],
            [
                26.08,
                1709614800
            ],
            [
                27.19,
                1709701200
            ],
            [
                26.79,
                1709787600
            ],
            [
                27.22,
                1709874000
            ],
            [
                28.37,
                1710129600
            ],
            [
                28.01,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10627,
        "drug_name": "Veklury (remdesivir)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "COVID-19 in people with mild, moderate and severe hepatic impairment",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-24",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/GILD\/news\/154678",
        "note": "Approved August 24, 2023.",
        "company_entity_id": 378,
        "company_ticker": "GILD",
        "company_name": "Gilead Sciences Inc.",
        "company_price": "75.0800",
        "company_change": -0.24,
        "company_percent_change": -0.31999999999999995,
        "company_optionable": 1,
        "company_number_of_shares": 1245774616,
        "price_change_sparkline": [
            [
                78.26,
                1706677200
            ],
            [
                78.16,
                1706763600
            ],
            [
                76.96,
                1706850000
            ],
            [
                76.71,
                1707109200
            ],
            [
                77.72,
                1707195600
            ],
            [
                74.42,
                1707282000
            ],
            [
                73.8,
                1707368400
            ],
            [
                73.67,
                1707454800
            ],
            [
                74.45,
                1707714000
            ],
            [
                73.53,
                1707800400
            ],
            [
                73.04,
                1707886800
            ],
            [
                73.37,
                1707973200
            ],
            [
                71.58,
                1708059600
            ],
            [
                72.04,
                1708405200
            ],
            [
                73.2,
                1708491600
            ],
            [
                72.78,
                1708578000
            ],
            [
                73.55,
                1708664400
            ],
            [
                72.95,
                1708923600
            ],
            [
                73.02,
                1709010000
            ],
            [
                72.7,
                1709096400
            ],
            [
                72.1,
                1709182800
            ],
            [
                72.31,
                1709269200
            ],
            [
                72.25,
                1709528400
            ],
            [
                72.99,
                1709614800
            ],
            [
                72.63,
                1709701200
            ],
            [
                73.66,
                1709787600
            ],
            [
                75.12,
                1709874000
            ],
            [
                75.32,
                1710129600
            ],
            [
                75.08,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3899,
        "drug_name": "Vadadustat",
        "clinical_trial_id": "NCT02865850",
        "has_trial_insight_page": 0,
        "indication": "Anemia due to chronic kidney disease (CKD)",
        "label": "NDA Filing",
        "value": "ndaFiling",
        "simplified_stage": "phase4",
        "stageid": 10,
        "stage_name": "NDA Filing",
        "date": "2023-08-24",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/AKBA\/news\/154665",
        "note": "NDA to be resubmitted, noted August 25, 2023.  Upon acceptance of the NDA, Akebia expects the FDA to set a PDUFA date of six months from the date of submission.",
        "company_entity_id": 27,
        "company_ticker": "AKBA",
        "company_name": "Akebia Therapeutics Inc.",
        "company_price": "1.4200",
        "company_change": -0.020000000000000018,
        "company_percent_change": -1.3900000000000001,
        "company_optionable": 1,
        "company_number_of_shares": 188389415,
        "price_change_sparkline": [
            [
                1.68,
                1706677200
            ],
            [
                1.71,
                1706763600
            ],
            [
                1.65,
                1706850000
            ],
            [
                1.65,
                1707109200
            ],
            [
                1.68,
                1707195600
            ],
            [
                1.65,
                1707282000
            ],
            [
                1.63,
                1707368400
            ],
            [
                1.64,
                1707454800
            ],
            [
                1.62,
                1707714000
            ],
            [
                1.52,
                1707800400
            ],
            [
                1.53,
                1707886800
            ],
            [
                1.47,
                1707973200
            ],
            [
                1.45,
                1708059600
            ],
            [
                1.44,
                1708405200
            ],
            [
                1.42,
                1708491600
            ],
            [
                1.39,
                1708578000
            ],
            [
                1.35,
                1708664400
            ],
            [
                1.51,
                1708923600
            ],
            [
                1.64,
                1709010000
            ],
            [
                1.54,
                1709096400
            ],
            [
                1.58,
                1709182800
            ],
            [
                1.71,
                1709269200
            ],
            [
                1.62,
                1709528400
            ],
            [
                1.6,
                1709614800
            ],
            [
                1.49,
                1709701200
            ],
            [
                1.46,
                1709787600
            ],
            [
                1.47,
                1709874000
            ],
            [
                1.44,
                1710129600
            ],
            [
                1.42,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9585,
        "drug_name": "Tyruko (natalizumab-sztn) biosimilar",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Multiple sclerosis (MS)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-25",
        "link": "https:\/\/www.novartis.com\/news\/media-releases\/sandoz-receives-fda-approval-tyruko-natalizumab-sztn-first-and-only-fda-approved-biosimilar-relapsing-forms-multiple-sclerosis#:~:text=Basel%2C%20August%2025%2C%202023%20%E2%80%93,)%2C%20developed%20by%20Polpharma%20Biologics.",
        "note": "Approved August 25, 2023.",
        "company_entity_id": 386,
        "company_ticker": "NVS",
        "company_name": "Novartis AG",
        "company_price": "99.7700",
        "company_change": -1.6,
        "company_percent_change": -1.58,
        "company_optionable": 1,
        "company_number_of_shares": 2044033986,
        "price_change_sparkline": [
            [
                99.701426650332,
                1706677200
            ],
            [
                101.493681927897,
                1706763600
            ],
            [
                99.9423211768864,
                1706850000
            ],
            [
                99.701426650332,
                1707109200
            ],
            [
                99.9615927390107,
                1707195600
            ],
            [
                99.6917908692698,
                1707282000
            ],
            [
                97.6682768462129,
                1707368400
            ],
            [
                97.3502960711611,
                1707454800
            ],
            [
                96.8685070180523,
                1707714000
            ],
            [
                95.4520472019125,
                1707800400
            ],
            [
                95.4424114208503,
                1707886800
            ],
            [
                96.0012867224565,
                1707973200
            ],
            [
                96.5408904619384,
                1708059600
            ],
            [
                98.9787430706688,
                1708405200
            ],
            [
                98.824570573674,
                1708491600
            ],
            [
                99.0558293191662,
                1708578000
            ],
            [
                100.115765236006,
                1708664400
            ],
            [
                99.4894394669641,
                1708923600
            ],
            [
                99.3930816563424,
                1709010000
            ],
            [
                98.49695401756,
                1709096400
            ],
            [
                97.2924813847881,
                1709182800
            ],
            [
                98.3427815205652,
                1709269200
            ],
            [
                98.2560594910056,
                1709528400
            ],
            [
                98.3813246448139,
                1709614800
            ],
            [
                98.9016568221714,
                1709701200
            ],
            [
                99.93,
                1709787600
            ],
            [
                100.71,
                1709874000
            ],
            [
                101.37,
                1710129600
            ],
            [
                99.77,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10635,
        "drug_name": "Estradiol Gel",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Severe vasomotor symptoms (hot flashes and night sweats) due to menopause",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-28",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ANIP\/news\/155047",
        "note": "Approved August 28, 2023.",
        "company_entity_id": 792,
        "company_ticker": "ANIP",
        "company_name": "ANI Pharmaceuticals Inc.",
        "company_price": "66.5400",
        "company_change": 0.41,
        "company_percent_change": 0.62,
        "company_optionable": 1,
        "company_number_of_shares": 21078986,
        "price_change_sparkline": [
            [
                55.82,
                1706677200
            ],
            [
                56.51,
                1706763600
            ],
            [
                55.42,
                1706850000
            ],
            [
                56.04,
                1707109200
            ],
            [
                56.87,
                1707195600
            ],
            [
                56.03,
                1707282000
            ],
            [
                55.91,
                1707368400
            ],
            [
                56.51,
                1707454800
            ],
            [
                57.03,
                1707714000
            ],
            [
                55.02,
                1707800400
            ],
            [
                56.1,
                1707886800
            ],
            [
                57.55,
                1707973200
            ],
            [
                59.72,
                1708059600
            ],
            [
                58.37,
                1708405200
            ],
            [
                57.63,
                1708491600
            ],
            [
                58.15,
                1708578000
            ],
            [
                59.13,
                1708664400
            ],
            [
                60.25,
                1708923600
            ],
            [
                59.94,
                1709010000
            ],
            [
                60.28,
                1709096400
            ],
            [
                67.67,
                1709182800
            ],
            [
                67.17,
                1709269200
            ],
            [
                66.42,
                1709528400
            ],
            [
                65.34,
                1709614800
            ],
            [
                65.81,
                1709701200
            ],
            [
                66.71,
                1709787600
            ],
            [
                67.42,
                1709874000
            ],
            [
                66.13,
                1710129600
            ],
            [
                66.54,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2360,
        "drug_name": "Reblozyl (luspatercept-aamt)",
        "clinical_trial_id": "NCT03682536",
        "has_trial_insight_page": 1,
        "indication": "First-line, lower-risk Myelodysplastic syndromes (MDS)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-28",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BMY\/news\/155298",
        "note": "Approved August 28, 2023.",
        "company_entity_id": 376,
        "company_ticker": "BMY",
        "company_name": "Bristol-Myers Squibb Company",
        "company_price": "54.4000",
        "company_change": 0.04,
        "company_percent_change": 0.07,
        "company_optionable": 1,
        "company_number_of_shares": 2022193411,
        "price_change_sparkline": [
            [
                48.87,
                1706677200
            ],
            [
                48.67,
                1706763600
            ],
            [
                48.71,
                1706850000
            ],
            [
                47.98,
                1707109200
            ],
            [
                49.26,
                1707195600
            ],
            [
                48.64,
                1707282000
            ],
            [
                48.71,
                1707368400
            ],
            [
                49.81,
                1707454800
            ],
            [
                49.75,
                1707714000
            ],
            [
                48.71,
                1707800400
            ],
            [
                48.89,
                1707886800
            ],
            [
                49.44,
                1707973200
            ],
            [
                49.86,
                1708059600
            ],
            [
                49.86,
                1708405200
            ],
            [
                50.91,
                1708491600
            ],
            [
                51.33,
                1708578000
            ],
            [
                51.66,
                1708664400
            ],
            [
                50.52,
                1708923600
            ],
            [
                50.51,
                1709010000
            ],
            [
                50.92,
                1709096400
            ],
            [
                50.75,
                1709182800
            ],
            [
                50.89,
                1709269200
            ],
            [
                50.92,
                1709528400
            ],
            [
                51.82,
                1709614800
            ],
            [
                53.38,
                1709701200
            ],
            [
                53.28,
                1709787600
            ],
            [
                53.79,
                1709874000
            ],
            [
                54.36,
                1710129600
            ],
            [
                54.4,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2360,
        "drug_name": "Reblozyl (luspatercept-aamt)",
        "clinical_trial_id": "NCT03682536",
        "has_trial_insight_page": 1,
        "indication": "First-line, lower-risk Myelodysplastic syndromes (MDS)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-08-28",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BMY\/news\/155298",
        "note": "Approved August 28, 2023.",
        "company_entity_id": 383,
        "company_ticker": "MRK",
        "company_name": "Merck & Company Inc.",
        "company_price": "122.6600",
        "company_change": -0.10999999999999999,
        "company_percent_change": -0.08999999999999997,
        "company_optionable": 1,
        "company_number_of_shares": 2532643872,
        "price_change_sparkline": [
            [
                120.78,
                1706677200
            ],
            [
                126.38,
                1706763600
            ],
            [
                126.41,
                1706850000
            ],
            [
                126.18,
                1707109200
            ],
            [
                126.88,
                1707195600
            ],
            [
                127.47,
                1707282000
            ],
            [
                126.61,
                1707368400
            ],
            [
                125.45,
                1707454800
            ],
            [
                125.34,
                1707714000
            ],
            [
                125.43,
                1707800400
            ],
            [
                125.82,
                1707886800
            ],
            [
                126.54,
                1707973200
            ],
            [
                127.79,
                1708059600
            ],
            [
                127.37,
                1708405200
            ],
            [
                128.12,
                1708491600
            ],
            [
                129.26,
                1708578000
            ],
            [
                129.45,
                1708664400
            ],
            [
                128.84,
                1708923600
            ],
            [
                129.03,
                1709010000
            ],
            [
                128.19,
                1709096400
            ],
            [
                127.15,
                1709182800
            ],
            [
                126.96,
                1709269200
            ],
            [
                124.05,
                1709528400
            ],
            [
                122.83,
                1709614800
            ],
            [
                123.75,
                1709701200
            ],
            [
                123.99,
                1709787600
            ],
            [
                123.5,
                1709874000
            ],
            [
                122.77,
                1710129600
            ],
            [
                122.66,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10648,
        "drug_name": "Abacavir (ABC)\/Dolutegravir (DTG)\/Lamivudine (3TC)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Children Living with HIV",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-05",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/VTRS\/news\/156393",
        "note": "Tentative approval announced September 5, 2023.",
        "company_entity_id": 851,
        "company_ticker": "VTRS",
        "company_name": "Viatris Inc.",
        "company_price": "12.0600",
        "company_change": 0.09,
        "company_percent_change": 0.75,
        "company_optionable": 1,
        "company_number_of_shares": 1187569149,
        "price_change_sparkline": [
            [
                11.6559127625202,
                1706677200
            ],
            [
                11.754943457189,
                1706763600
            ],
            [
                11.7351373182553,
                1706850000
            ],
            [
                11.4677544426494,
                1707109200
            ],
            [
                11.7747495961228,
                1707195600
            ],
            [
                11.6262035541195,
                1707282000
            ],
            [
                11.4479483037157,
                1707368400
            ],
            [
                11.5667851373183,
                1707454800
            ],
            [
                11.8341680129241,
                1707714000
            ],
            [
                11.8539741518578,
                1707800400
            ],
            [
                11.9530048465267,
                1707886800
            ],
            [
                12.6957350565428,
                1707973200
            ],
            [
                12.933408723748,
                1708059600
            ],
            [
                13.1116639741519,
                1708405200
            ],
            [
                13.1314701130856,
                1708491600
            ],
            [
                13.2305008077544,
                1708578000
            ],
            [
                13.3988529886914,
                1708664400
            ],
            [
                13.2998222940226,
                1708923600
            ],
            [
                13.101760904685,
                1709010000
            ],
            [
                12.1708723747981,
                1709096400
            ],
            [
                12.2500969305331,
                1709182800
            ],
            [
                12.4679644588045,
                1709269200
            ],
            [
                12.2401938610662,
                1709528400
            ],
            [
                12.1609693053312,
                1709614800
            ],
            [
                12.0817447495961,
                1709701200
            ],
            [
                12.2104846526656,
                1709787600
            ],
            [
                12.26,
                1709874000
            ],
            [
                11.97,
                1710129600
            ],
            [
                12.06,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10036,
        "drug_name": "Crovalimab - (COMMODORE 1 + 2)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Paroxysmal nocturnal hemoglobinuria (PNH)",
        "label": "BLA Filing",
        "value": "blaFiling",
        "simplified_stage": "phase4",
        "stageid": 12,
        "stage_name": "BLA Filing",
        "date": "2023-09-06",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/RHHBY\/news\/156793",
        "note": "BLA accepted by FDA, noted Septemeber 6, 2023",
        "company_entity_id": 536,
        "company_ticker": "RHHBY",
        "company_name": "Roche Holding AG ADR",
        "company_price": "35.1500",
        "company_change": 0.54,
        "company_percent_change": 1.56,
        "company_optionable": 0,
        "company_number_of_shares": 6389213336,
        "price_change_sparkline": [
            [
                35.14,
                1706677200
            ],
            [
                34.32,
                1706763600
            ],
            [
                33.95,
                1706850000
            ],
            [
                33.16,
                1707109200
            ],
            [
                33.27,
                1707195600
            ],
            [
                32.55,
                1707282000
            ],
            [
                32.1,
                1707368400
            ],
            [
                32.31,
                1707454800
            ],
            [
                32.6,
                1707714000
            ],
            [
                32.13,
                1707800400
            ],
            [
                32.02,
                1707886800
            ],
            [
                32.1,
                1707973200
            ],
            [
                32.28,
                1708059600
            ],
            [
                32.74,
                1708405200
            ],
            [
                32.91,
                1708491600
            ],
            [
                32.49,
                1708578000
            ],
            [
                32.96,
                1708664400
            ],
            [
                32.52,
                1708923600
            ],
            [
                33.03,
                1709010000
            ],
            [
                32.93,
                1709096400
            ],
            [
                32.73,
                1709182800
            ],
            [
                33.08,
                1709269200
            ],
            [
                32.88,
                1709528400
            ],
            [
                33.15,
                1709614800
            ],
            [
                33.47,
                1709701200
            ],
            [
                33.77,
                1709787600
            ],
            [
                33.9,
                1709874000
            ],
            [
                34.61,
                1710129600
            ],
            [
                35.15,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5829,
        "drug_name": "AT-007 - (ACTION-Galactosemia kids)",
        "clinical_trial_id": "NCT04902781",
        "has_trial_insight_page": 1,
        "indication": "Galactosemia",
        "label": "NDA Filing",
        "value": "ndaFiling",
        "simplified_stage": "phase4",
        "stageid": 10,
        "stage_name": "NDA Filing",
        "date": "2023-09-06",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/APLT\/news\/156854",
        "note": "Company pre-NDA meeting with the FDA completed, noted September 6, 2023. NDA submission expected 4Q 2023.",
        "company_entity_id": 665,
        "company_ticker": "APLT",
        "company_name": "Applied Therapeutics Inc.",
        "company_price": "6.0100",
        "company_change": -0.32999999999999996,
        "company_percent_change": -5.21,
        "company_optionable": 1,
        "company_number_of_shares": 105886831,
        "price_change_sparkline": [
            [
                3.13,
                1706677200
            ],
            [
                3.12,
                1706763600
            ],
            [
                3.02,
                1706850000
            ],
            [
                3.01,
                1707109200
            ],
            [
                3.14,
                1707195600
            ],
            [
                2.8,
                1707282000
            ],
            [
                2.71,
                1707368400
            ],
            [
                2.78,
                1707454800
            ],
            [
                2.82,
                1707714000
            ],
            [
                2.72,
                1707800400
            ],
            [
                2.68,
                1707886800
            ],
            [
                3.75,
                1707973200
            ],
            [
                5.38,
                1708059600
            ],
            [
                5.31,
                1708405200
            ],
            [
                5.13,
                1708491600
            ],
            [
                5.6,
                1708578000
            ],
            [
                5.74,
                1708664400
            ],
            [
                5.3,
                1708923600
            ],
            [
                5.58,
                1709010000
            ],
            [
                7.4,
                1709096400
            ],
            [
                7.12,
                1709182800
            ],
            [
                7.07,
                1709269200
            ],
            [
                6.9,
                1709528400
            ],
            [
                6.17,
                1709614800
            ],
            [
                6.46,
                1709701200
            ],
            [
                6.62,
                1709787600
            ],
            [
                6.93,
                1709874000
            ],
            [
                6.34,
                1710129600
            ],
            [
                6.01,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 10654,
        "drug_name": "Lisdexamfetamine Dimesylate  (Vyvanse generic)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Attention Deficit Hyperactivity Disorder (ADHD)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-06",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/AMRX\/news\/156937",
        "note": "ANDA approved September 6, 2023.",
        "company_entity_id": 543,
        "company_ticker": "AMRX",
        "company_name": "Amneal Pharmaceuticals Inc.",
        "company_price": "5.3100",
        "company_change": -0.06999999999999995,
        "company_percent_change": -1.3,
        "company_optionable": 1,
        "company_number_of_shares": 306544199,
        "price_change_sparkline": [
            [
                5.35,
                1706677200
            ],
            [
                5.51,
                1706763600
            ],
            [
                5.52,
                1706850000
            ],
            [
                5.52,
                1707109200
            ],
            [
                5.6,
                1707195600
            ],
            [
                5.36,
                1707282000
            ],
            [
                5.46,
                1707368400
            ],
            [
                5.57,
                1707454800
            ],
            [
                5.85,
                1707714000
            ],
            [
                5.6,
                1707800400
            ],
            [
                5.82,
                1707886800
            ],
            [
                5.89,
                1707973200
            ],
            [
                5.9,
                1708059600
            ],
            [
                5.78,
                1708405200
            ],
            [
                5.73,
                1708491600
            ],
            [
                5.69,
                1708578000
            ],
            [
                5.8,
                1708664400
            ],
            [
                5.82,
                1708923600
            ],
            [
                5.71,
                1709010000
            ],
            [
                5.52,
                1709096400
            ],
            [
                5.52,
                1709182800
            ],
            [
                5.47,
                1709269200
            ],
            [
                5.4,
                1709528400
            ],
            [
                5.34,
                1709614800
            ],
            [
                5.31,
                1709701200
            ],
            [
                5.31,
                1709787600
            ],
            [
                5.39,
                1709874000
            ],
            [
                5.38,
                1710129600
            ],
            [
                5.31,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10655,
        "drug_name": "Calcium gluconate in sodium chloride injection",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Acute symptomatic hypocalcemia in pediatric and adult patients",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-06",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/AMRX\/news\/157099",
        "note": "FDA ANDA Approved based on FDA's Competitive Generic Therapy (CGT) designation with 180-day exclusivity on September 6, 2023.",
        "company_entity_id": 543,
        "company_ticker": "AMRX",
        "company_name": "Amneal Pharmaceuticals Inc.",
        "company_price": "5.3100",
        "company_change": -0.06999999999999995,
        "company_percent_change": -1.3,
        "company_optionable": 1,
        "company_number_of_shares": 306544199,
        "price_change_sparkline": [
            [
                5.35,
                1706677200
            ],
            [
                5.51,
                1706763600
            ],
            [
                5.52,
                1706850000
            ],
            [
                5.52,
                1707109200
            ],
            [
                5.6,
                1707195600
            ],
            [
                5.36,
                1707282000
            ],
            [
                5.46,
                1707368400
            ],
            [
                5.57,
                1707454800
            ],
            [
                5.85,
                1707714000
            ],
            [
                5.6,
                1707800400
            ],
            [
                5.82,
                1707886800
            ],
            [
                5.89,
                1707973200
            ],
            [
                5.9,
                1708059600
            ],
            [
                5.78,
                1708405200
            ],
            [
                5.73,
                1708491600
            ],
            [
                5.69,
                1708578000
            ],
            [
                5.8,
                1708664400
            ],
            [
                5.82,
                1708923600
            ],
            [
                5.71,
                1709010000
            ],
            [
                5.52,
                1709096400
            ],
            [
                5.52,
                1709182800
            ],
            [
                5.47,
                1709269200
            ],
            [
                5.4,
                1709528400
            ],
            [
                5.34,
                1709614800
            ],
            [
                5.31,
                1709701200
            ],
            [
                5.31,
                1709787600
            ],
            [
                5.39,
                1709874000
            ],
            [
                5.38,
                1710129600
            ],
            [
                5.31,
                1710216000
            ]
        ],
        "statuses": []
    }
]